In contrast, transfer of rmInα primed CD8+ T cells failed to provide protection against the growth of I-10 TSC tumors (Fig. 3c) or enhancement of overall survival (Fig. 3d). The gene discussed is CD8A; the disease is tuberous sclerosis.